Back
Entrada Therapeutics Stock Predictions
Sponsored
TRDA
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
37
TRDA
Entrada Therapeutics
Last Price:
$17.60
Seasonality Move:
-24.47%
7 Day Trial
ALL ACCESS PASS
$
7
These 7 Stocks Will Be Magnificent in 2025
Get Your Copy of "These 7 Stocks Will Be Magnificent in 2025" Here.Entrada Therapeutics Stock Forecast
-
Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 11% based on the past 3 years of stock performance.
-
Entrada Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Entrada Therapeutics Stock Undervalued?The current Entrada Therapeutics [TRDA] share price is $17.60. The Score for TRDA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
-
TRDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Entrada Therapeutics Stock Go Up Next Year?
-
Over the next 52 weeks, Entrada Therapeutics has on average historically risen by 11% based on the past 3 years of stock performance.
Entrada Therapeutics Stock Rating
Sell
37
Entrada Therapeutics (TRDA)
is a Sell
Is Entrada Therapeutics overpriced?
-
Entrada Therapeutics has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Entrada Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com
52-Week Data
52-Week High:
21.79
52-Week Low:
11.35
Prediction Charts
Market Cap:
658.6M
Price in USD:
17.60
Volume:
357.3K
Beta:
-0.18
Technical Analysis
SMA50:
18.48
SMA100:
17.04
SMA200:
15.77
52-Wk Change:
17.41%
Stock Predictions
-
Is Entrada Therapeutics stock public?Yes, Entrada Therapeutics is a publicly traded company.
-
What is the Entrada Therapeutics stock quote today?The Entrada Therapeutics stock price is 17.60 USD today.
-
How to buy Entrada Therapeutics stock online?You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-3 | 20.32 | 20.17 | 20.50 | 19.98 |
Dec-4 | 20.18 | 19.96 | 20.26 | 19.60 |
Dec-5 | 19.90 | 20.32 | 20.46 | 19.58 |
Dec-6 | 20.81 | 21.59 | 21.63 | 20.48 |
Dec-9 | 21.75 | 21.52 | 21.79 | 21.19 |
Dec-10 | 21.37 | 20.51 | 21.46 | 20.37 |
Dec-11 | 20.53 | 19.90 | 21.08 | 19.86 |
Dec-12 | 19.74 | 18.12 | 19.93 | 18.05 |
Dec-13 | 17.93 | 17.66 | 17.93 | 17.26 |
Dec-16 | 17.61 | 18.01 | 18.46 | 17.28 |
Dec-17 | 17.89 | 18.45 | 18.54 | 17.83 |
Dec-18 | 18.50 | 17.11 | 18.96 | 17.00 |
Dec-19 | 17.11 | 17.28 | 17.68 | 16.86 |
Dec-20 | 16.86 | 17.60 | 18.00 | 16.86 |
Entrada Therapeutics Earnings
Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Entrada Therapeutics Forecast Revenue Growth
Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.13 per share, and a decrease next year of $4.09 per share.
* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.